Fig. 4From: Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in ratsEstimation of the rate constant for the transfer of 11C-erlotinib from plasma into tissues. Integration plots of 11C-erlotinib uptake by the liver (a), kidneys (b), and lungs (c) are shown. Kuptake values are reported in d. Data are mean (n = 4) ± 1. S.D. *** p < 0.001; ** p < 0.01; n.s non-significantBack to article page